NeuroPace, Inc. NPCE
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 22.83M | 22.07M | 26.59M | 27.35M | 19.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.83M | 22.07M | 26.59M | 27.35M | 19.50M |
| Cost of Revenue | 3.92M | 4.02M | 6.01M | 6.19M | 3.29M |
| Gross Profit | 18.91M | 18.05M | 20.58M | 21.17M | 16.21M |
| SG&A Expenses | 17.15M | 16.43M | 15.32M | 17.19M | 17.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.97M | 27.64M | 28.36M | 29.95M | 27.69M |
| Operating Income | -5.14M | -5.57M | -1.77M | -2.60M | -8.19M |
| Income Before Tax | -6.20M | -6.69M | -2.73M | -3.50M | -10.02M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.20M | -6.69M | -2.73M | -3.50M | -10.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 1.37M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.20M | -6.69M | -2.73M | -3.50M | -8.65M |
| EBIT | -5.14M | -5.57M | -1.77M | -2.60M | -8.19M |
| EBITDA | -5.08M | -5.51M | -1.69M | -2.55M | -8.13M |
| EPS Basic | -0.18 | -0.20 | -0.08 | -0.11 | -0.26 |
| Normalized Basic EPS | -0.11 | -0.12 | -0.05 | -0.07 | -0.18 |
| EPS Diluted | -0.18 | -0.20 | -0.08 | -0.11 | -0.26 |
| Normalized Diluted EPS | -0.11 | -0.12 | -0.05 | -0.07 | -0.18 |
| Average Basic Shares Outstanding | 34.10M | 33.72M | 33.39M | 33.13M | 32.86M |
| Average Diluted Shares Outstanding | 34.10M | 33.72M | 33.39M | 33.13M | 32.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |